Dendritic cells and T cells in immunotherapy

O'Neill, D.W.

Journal of Drugs in Dermatology Jdd 9(11): 1383-1392

2010


ISSN/ISBN: 1545-9616
PMID: 21061761
Document Number: 11940
Autologous cellular immunotherapies have been used experimentally in humans to treat many types of cancer. These therapies are divided into two principal types: active cellular immunotherapies that rely on autologous dendritic cells or other antigen presenting cells; and adoptive T-cell therapies, in which large numbers of antigen-specific T lymphocytes are propagated ex vivo and then infused back into the patient. With the FDA approval of the antigen presenting cell vaccine sipuleucel-T for prostate cancer, active immunization has become an accepted approach for the treatment of established cancer.

Document emailed within 1 workday
Secure & encrypted payments

Dendritic cells and T cells in immunotherapy